M1231 – Patient receives hcv antibody test with nonreactive result

Long description

Patient receives hcv antibody test with nonreactive result

Short description

Pt hcv tst no reactive res

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

Z2 Undefined codes

Added

January 1, 2024

Last change

January 1, 2024 – No change

Nearby M codes

• M1223 – Glaucoma plan of care documented
• M1224 – Intraocular pressure (iop) reduced by a value less than 20% from the pre-intervention level
• M1225 – Intraocular pressure (iop) reduced by a value of greater than or equal to 20% from the pre-intervention level
• M1226 – Iop measurement not documented, reason not otherwise specified
• M1227 – Evidence-based therapy was prescribed
• M1228 – Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, has hcv treatment initiated within 3 months of the reactive hcv antibody test
• M1229 – Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, is referred within 1 month of the reactive hcv antibody test to a clinician who treats hcv infection
• M1230 – Patient has a reactive hcv antibody test and does not have a follow up hcv viral test, or patient has a reactive hcv antibody test and has a follow up hcv viral test that detects hcv viremia and is not referred to a clinician who treats hcv infection within 1 month and does not have hcv treatment initiated within 3 months of the reactive hcv antibody test, reason not given
• M1232 – Patient receives hcv antibody test with reactive result
• M1233 – Patient does not receive hcv antibody test or patient does receive hcv antibody test but results not documented, reason not given
• M1234 – Patient has a reactive hcv antibody test, and has a follow up hcv viral test that does not detect hcv viremia
• M1235 – Documentation or patient report of hcv antibody test or hcv rna test which occurred prior to the performance period
• M1236 – Baseline mrs > 2
• M1237 – Patient reason for not screening for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety (e.g., patient declined or other patient reasons)
• M1238 – Documentation that administration of second recombinant zoster vaccine could not occur during the performance period due to the recommended 2-6 month interval between doses (i.e, first dose received after october 31)
• M1239 – Patient did not respond to the question of patient felt heard and understood by this provider and team